No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract Obinutuzumab plus lenalidomide is an active and safe therapy in advanced, previously untreated follicular lymphoma

GALEN regimen, Phase 2 trial

byKathleen Lau

December 31, 2021

in StudyGraphics

Reading Time: 1 min read

RELATED REPORTS

Intra-arterial tenecteplase has limited use after successful endovascular recanalisation of acute posterior circulation arterial occlusion

The Scan by 2 Minute Medicine®: Another Viral Virus, Is One Drink Too Much?, Eggs, Humans, and the Flu, and Detrimental Exercise:

2 Minute Medicine Rewind January 20, 2025

Tags: #cancer advanced follicular lymphoma advanced lymphoma blood blood cancer cancer chemo-free chemotherapy complete response rate CRR efficacy outcomes febrile neutropenia FL follicular lymphoma GALEN hematology high tumor burden high tumour burden induction infection infusion-related reaction IWG 1999 Criteria lenalidomide maintenance neutropenia Obinutuzumab oncology os overall survival pfs previously untreated lymphoma progression-free survival skin reaction survival outcomes untreated lymphoma

Moderate caffeine intake may not be associated with cardiometabolic pregnancy complications

RelatedReports

Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults

Emergency

Intra-arterial tenecteplase has limited use after successful endovascular recanalisation of acute posterior circulation arterial occlusion

January 22, 2025

The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Another Viral Virus, Is One Drink Too Much?, Eggs, Humans, and the Flu, and Detrimental Exercise:

January 21, 2025

Cervical cancer screening practices less cost-effective than suggested guidelines

Weekly Rewinds

2 Minute Medicine Rewind January 20, 2025

January 20, 2025

Dacomitinib may be effective in EGFR-associated lung cancer

Chronic Disease

Neoadjuvant Nivolumab/Ipilimumab Vs Chemotherapy in Resectable NSCLC

January 13, 2025

Influenza vaccine not associated with increased risk of epilepsy in children

Immune dysfunction is associated with a higher risk of breakthrough COVID-19 infection

2 Minute Medicine Rewind January 3, 2022

Kangaroo mother care linked to better neonatal outcomes

Mediterranean diet and mindfulness-strategies reduced risk of low-birth-weight newborns

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result